ICD-10-PCS Code Range for Determining the level of a physiological or physical function at a point in time
ICD-10-PCS Code Range for Determining the level of a physiological or physical function at a point in time is medical classification list by Centers for Medicare and Medicaid Services (CMS).
ICD-10-PCS code range (XXE), contains ICD-10-PCS codes for Nervous System, New Technology, Physiological Systems, Determining the level of a physiological or physical function at a point in time.
PCS Tables
| X New Technology |
| X Physiological Systems |
| E Measurement: Determining the level of a physiological or physical function at a point in time |
| Body Part | Approach | Device / Substance / Technology | Qualifier |
|---|---|---|---|
| Character 4 | Character 5 | Character 6 | Character 7 |
Body System (Character 4)
0 Central Nervous | Approach (Character 5) X External | Substance (Character 6) 0 Intracranial Vascular Activity, Computer-aided Assessment | Qualifier (Character 7) 7 New Technology Group 7 | Body System (Character 4)
0 Central Nervous | Approach (Character 5) X External | Substance (Character 6) 4 Brain Electrical Activity, Computer-aided Semiologic Analysis | Qualifier (Character 7) 8 New Technology Group 8 | Body System (Character 4)
2 Cardiac | Approach (Character 5) X External | Substance (Character 6) 1 Output, Computer-aided Assessment | Qualifier (Character 7) 9 New Technology Group 9 | Body System (Character 4)
3 Arterial | Approach (Character 5) X External | Substance (Character 6) 2 Pulmonary Artery Flow, Computer-aided Triage and Notification | Qualifier (Character 7) 7 New Technology Group 7 | Body System (Character 4)
3 Arterial | Approach (Character 5) X External | Substance (Character 6) 5 Coronary Artery Flow, Quantitative Flow Ratio Analysis6 Coronary Artery Flow, Computer-aided Valve Modeling and Notification | Qualifier (Character 7) 8 New Technology Group 8 | Body System (Character 4)
5 Circulatory | Approach (Character 5) X External | Substance (Character 6) 3 Infection, Whole Blood Reverse Transcription and Quantitative Real-time Polymerase Chain Reaction | Qualifier (Character 7) 8 New Technology Group 8 | Body System (Character 4)
5 Circulatory | Approach (Character 5) X External | Substance (Character 6) M Infection, Whole Blood Nucleic Acid-base Microbial Detection | Qualifier (Character 7) 5 New Technology Group 5 | Body System (Character 4)
5 Circulatory | Approach (Character 5) X External | Substance (Character 6) N Infection, Positive Blood Culture Fluorescence Hybridization for Organism Identification, Concentration and Susceptibility | Qualifier (Character 7) 6 New Technology Group 6 | Body System (Character 4)
5 Circulatory | Approach (Character 5) X External | Substance (Character 6) R Infection, Mechanical Initial Specimen Diversion Technique Using Active Negative PressureT Intracranial Arterial Flow, Whole Blood mRNA V Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection | Qualifier (Character 7) 7 New Technology Group 7 | Body System (Character 4)
5 Circulatory | Approach (Character 5) X External | Substance (Character 6) Y Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology | Qualifier (Character 7) 9 New Technology Group 9 | Body System (Character 4)
9 Nose | Approach (Character 5) 7 Via Natural or Artificial Opening | Substance (Character 6) U Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction | Qualifier (Character 7) 7 New Technology Group 7 | Body System (Character 4)
B Respiratory | Approach (Character 5) X External | Substance (Character 6) Q Infection, Lower Respiratory Fluid Nucleic Acid-base Microbial Detection | Qualifier (Character 7) 6 New Technology Group 6 |